Clinical Trials Browser

OTHER × Sepsis × telavancin × Clear all

NCT01321879 2019-12-27

Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients

Phase 2 Completed

40 enrolled 6 charts

Infections, Staphylococcal Infections, Bacteremia, Sepsis